Announcements Trials
Browse Landscape

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 24Observational 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Carcinoma, Non-Small-Cell Lung 13Melanoma 11Lung Neoplasms 6Squamous Cell Carcinoma of Head and Neck 5Neoplasms 5Head and Neck Neoplasms 3Carcinoma, Renal Cell 3Colorectal Neoplasms 2Carcinoma, Hepatocellular 2Biliary Tract Neoplasms 2Urinary Bladder Neoplasms 1Uncommon Pathological Types of Lung Cancer 1Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Stomach Neoplasms 1Skin Neoplasms 1Sexual Dysfunction, Physiological 1Sarcopenia 1Prostatic Neoplasms 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Pancreatic Neoplasms 1Oropharyngeal Neoplasms 1Neoplasms, Squamous Cell 1Neoplasm Metastasis 1NSCLC 1Motor Activity 1Lung Squamous Cell Carcinoma Stage IV 1Lung Diseases, Interstitial 1Liver Diseases 1Kidney Neoplasms 1

Interventions

Liquid Biopsy 4Blood Specimen Collection 4Gemcitabine 3pembrolizumab 2Immunohistochemistry 2Cisplatin 2Capecitabine 2Base Sequence 2130-nm albumin-bound paclitaxel 2tislelizumab 1taxane 1lenvatinib 1irinotecan sucrosofate 1gemcitabine-oxaliplatin regimen 1Tegafur 1Taxes 1Surgical Procedures, Operative 1Standard of Care 1S 1 (combination) 1Polymerase Chain Reaction 1Platinum Compounds 1Oxaliplatin 1Nivolumab 1Microscopy, Confocal 1Methylation 1Mass Spectrometry 1Leucovorin 1Irinotecan 1Immune Checkpoint Inhibitors 1High-Throughput Nucleotide Sequencing 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Biliary Tract Neoplasms × pembrolizumab × Clear all
NCT06648057 2026-03-18

Investigation of Predictive Biomarkers in Patients With Advanced BTC Treated With Lenvatinib Plus Pembrolizumab

CHA University

Recruiting
100 enrolled
Gastrointestinal

Biliary Tract Neoplasms, Cholangiocarcinoma

NCT03695952 2025-01-28

A Prospective Cohort Study of Patients with Hepatobiliary Cancer Treated with Immune Checkpoint Inhibitors

Asan Medical Center

Active not recruiting
100 enrolled
Gastrointestinal

Biliary Tract Neoplasms, Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡